Engel, MA; Neurath, MF
New pathophysiological insights and modern treatment of IBDJOURNAL OF GASTROENTEROLOGY. Bd. 45. H. 6. 2010 S. 571-583
Ertle, JM; Dechene, A; Sowa, JP et al.
NON-ALCOHOLIC FATTY LIVER DISEASE PROGRESSES TO HCC IN THE ABSENCE OF CIRRHOSIS RUNNING HEAD: ABSENCE OF CIRRHOSIS IN NASH DERIVED HCCHEPATOLOGY. Bd. 52. H. 4. 2010 S. 1154A-1154A
Worns, MA; Galle, PR
Novel inhibitors in development for hepatocellular carcinomaEXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 19. H. 5. 2010 S. 615-629
Marker-Hermann, E; Bolten, W
Obituary Professor Klaus Miehlke. He is a doctor of rheumatology, orthopedic and psychosomatic. He published several works.ZEITSCHRIFT FUR RHEUMATOLOGIE. Bd. 69. H. 1. 2010 S. 94-94
Neumann, H; Vieth, M; Mudter, J et al.
Panendoscopic characterization of Peutz-Jeghers syndromeENDOSCOPY. Bd. 42. 2010 S. E235-E235
Konkel, JE; Frommer, F; Leech, MD et al.
PD-1 signalling in CD4+T cells restrains their clonal expansion to an immunogenic stimulus, but is not critically required for peptide-induced toleranceIMMUNOLOGY. Bd. 130. H. 1. 2010 S. 92-102
Waldner, MJ; Wirtz, S; Becker, C et al.
Perforin Deficiency Attenuates Inflammation and Tumor Growth in Colitis-Associated CancerINFLAMMATORY BOWEL DISEASES. Bd. 16. H. 4. 2010 S. 559-567
Trarbach, T; Moehler, M; Heinemann, V et al.
Phase II trial of mapatumumab, a fully human agonistic monoclonal antibody that targets and activates the tumour necrosis factor apoptosis-inducing ligand receptor-1 (TRAIL-R1), in patients with refractory colorectal cancerBRITISH JOURNAL OF CANCER. Bd. 102. H. 3. 2010 S. 506-512
Stellos, K; Kopf, S; Paul, A et al.
Platelets in RegenerationSEMINARS IN THROMBOSIS AND HEMOSTASIS. Bd. 36. H. 2. 2010 S. 175-184
Herzer, K; Carbow, A; Sydor, S et al.
PML-DEFICIENCY TRIGGERS HCV-ASSOCIATED HCC DEVELOPMENT IN MICEHEPATOLOGY. Bd. 52. H. 4. 2010 S. 580A-581A